Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-22

FDA Approved: LUPRON DEPOT-PED — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lupron Depot-Ped (leuprolide acetate) from AbbVie Inc. The approval updates the product's labeling to reflect th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUPRON DEPOT-PED (Leuprolide acetate)

Snippet

SUPPL AP for LUPRON DEPOT-PED (LEUPROLIDE ACETATE)